Skip to main content
. 2024 Nov 12;15:1487250. doi: 10.3389/fimmu.2024.1487250

Table 1.

Mass spectrometry data from ALλ(CLA) or ALκ(TAL) patient tissue.

# Identified Protein ALλ(CLA) ALκ(TAL) # Identified Protein ALλ(CLA) ALκ(TAL)
1 Igκ constant chain 4002 16 Pelamin-A/C 1 119
2 Igκ variable chain 444 17 Histone H2A-T1H 55 639
3 Igλ constant chain 2472 18 HSPG 537 175
4 Igλ variable chain 457 19 Fibronectin 48 342
5 ApoA-IV 873 51 20 Tubulin α-chain 6 41
6 ApoE 725 1376 21 Tubulin β-chain 4 82
7 SAP 261 408 22 β-hemoglobin 278 56
8 Serum albumin 28 89 23 Collagen-α3 414 913
9 Myosin-9 23 88 24 Histone H3 5 173
10 Histone H2B-T1K 85 853 25 Complement C3 306 111
11 Vimentin 50 840 26 Complement C1q 51 65
12 Actin 149 786 27 Histone H2A-T1C 245
13 Histon H4 60 939 28 Filamin-A 2 11
14 Vitronectin 95 1572 29 Tenascin 26 10
15 Clusterin 1265 1893 30 Collagen-α2 182 32

Amyloidogenic proteins identified are listed first, followed by the most abundant proteins. Numbers indicate the number of peptide spectra observed for each protein.